跳转至内容
Merck
CN
所有图片(1)

主要文件

查看所有文档

80822

Supelco

(S)-Naproxen methyl ester

pharmaceutical impurity standard

别名:

Naproxen Impurity E (PhEur), (2S)-2-(6-Methoxy-2-naphthyl)propionic acid methyl ester, Methyl (αS)-6-methoxy-α-methyl-2-naphthaleneacetate, Methyl (2S)-2-(6-methoxynaphthalen-2-yl)propanoate

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C15H16O3
CAS号:
26159-35-3
分子量:
244.29
Beilstein:
4352971
MDL编号:
MFCD12031841
UNSPSC代码:
12352108
PubChem化学物质编号:
329769059
NACRES:
NA.24

质量水平

100

API类

naproxen

方案

≥98.0% (HPLC)

旋光性

[α]/D 72.0 to 84.0°, c = 0.1 in chloroform

保质期

limited shelf life, expiry date on the label

杂质

≤0.5% water

mp

87 °C

应用

pharmaceutical (small molecule)

包装形式

neat

储存温度

2-8°C

SMILES字符串

C[C@H](C(OC)=O)C1=CC2=CC=C(OC)C=C2C=C1

InChI

1S/C15H16O3/c1-10(15(16)18-3)11-4-5-13-9-14(17-2)7-6-12(13)8-11/h4-10H,1-3H3/t10-/m0/s1

InChI key

ZFYFBPCRUQZGJE-JTQLQIEISA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

一般描述

(S)-Naproxen methyl ester is an ester of the non-steroidal, anti-inflammatory drug, (S)-naproxen

相关产品

产品编号
说明
价格

PHR1040

萘普生, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1165

萘普生 钠, Pharmaceutical Secondary Standard; Certified Reference Material

1457301

萘普生, United States Pharmacopeia (USP) Reference Standard

N0250000

萘普生, European Pharmacopoeia (EP) Reference Standard

Y0000399

萘普生, European Pharmacopoeia (EP) Reference Standard

Y0000631

萘普生杂质L, European Pharmacopoeia (EP) Reference Standard

1457403

萘普生 钠, United States Pharmacopeia (USP) Reference Standard

1457312

6-甲氧基-2-萘甲酸, United States Pharmacopeia (USP) Reference Standard

1457425

6′-甲氧基-2′-萘乙酮, United States Pharmacopeia (USP) Reference Standard

08129

6-甲氧基-2-萘酚, pharmaceutical impurity standard

79584

2-Ethyl-6-methoxynaphthalene, pharmaceutical impurity standard

80713

(1RS)-1-(6-Methoxynaphthalen-2-yl)ethanol, pharmaceutical impurity standard

82170

(R)-(-)-6-甲氧基-α-甲基-2-萘乙酸, pharmaceutical impurity standard

07506

(S)-Naproxen ethyl ester, pharmaceutical impurity standard

80816

(2S)-2-(5-Chloro-6-methoxynaphthalen-2-yl)propanoic acid, pharmaceutical impurity standard

80821

(2S)-2-(5-Iodo-6-methoxynaphthalen-2-yl)propanoic acid, pharmaceutical impurity standard

80818

(2S)-2-(5-Bromo-6-methoxynaphthalen-2-yl)propanoic acid, pharmaceutical impurity standard

07503

2-溴-6-甲氧基萘, pharmaceutical impurity standard

07499

2-甲氧基萘, pharmaceutical impurity standard

07547

6-甲氧基-2-萘甲酸, pharmaceutical impurity standard

BP435

萘普生, British Pharmacopoeia (BP) Reference Standard

1457436

(R)-(-)-6-甲氧基-α-甲基-2-萘乙酸, United States Pharmacopeia (USP) Reference Standard

PHR2254

萘普生, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2256

Naproxen 1,3-Butylene Glycol Esters, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2219

Naproxen 1,2 Propylene Glycol Esters, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2248

Naproxen 2,3-Butylene Glycol Ester, pharmaceutical secondary standard

PHR2257

萘普生异丙酯, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2524

萘普生杂质N, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2525

萘普生杂质M, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2527

Naproxen Related Compound A, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2526

6-甲氧基-2-萘酚, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2520

Naproxen Impurity B, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2519

Naproxen Impurity C, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2518

(R)-(-)-6-甲氧基-α-甲基-2-萘乙酸, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2523

萘普生相关化合物L, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2530

rac-Naproxen, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2517

萘普生相关化合物K, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2521

萘普生杂质A, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2522

萘普生杂质I, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2528

萘普生杂质F, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2529

萘普生杂质E, Pharmaceutical Secondary Standard; Certified Reference Material

警示用语：

Warning

危险分类

Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT SE 3

靶器官

Respiratory system

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
BCCL1358
BCCG3339
BCCC6676
BCBZ8488
BCBW3533

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Enantioselective hydrolysis of racemic naproxen methyl ester by two-step acetone-treated Candida rugosa lipase.
Lee GE, et al.
Process Biochemistry (Oxford, United Kingdom), 37(3), 293-298 (2001)
Bulletin of the Chemical Society of Japan, 77(1-4) (2004)
Sammy Ferri-Borgogno et al.
Cancers, 12(9) (2020-09-25)
Background & Aims: ARID1A is postulated to be a tumor suppressor gene owing to loss-of-function mutations in human pancreatic ductal adenocarcinomas (PDAC). However, its role in pancreatic pathogenesis is not clear despite recent studies using genetically engineered mouse (GEM) models.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门